#Japan #healthcare #Tokyo #digital health #Doctors Brain™

Introduction

Doctors Inc., based in Minato-ku, Tokyo, has announced the launch of its new service, Doctors Brain™, on June 8, 2026. This unique offering supports companies aiming to enter or expand in the healthcare sector, providing vital expertise in medical and healthcare business development.

Addressing Healthcare Development Risks

The main risk in developing healthcare projects is often the slow validation process. Many companies find that their products aren't utilized after development, often resulting in costly reworks amounting to millions of yen, or worse, withdrawal from business altogether. Doctors Brain™ aims to mitigate this risk by organizing insights from over 400 past partnerships with healthcare businesses, facilitating valuable information from physicians to enhance project success from concept inception to execution—starting from a low monthly fee of ¥50,000.

Background: A Growing Market Yet Many Failures

While the Japanese healthcare market continues to grow, many startups in the sector fail to reach actualization, mainly due to a lack of real information from medical practices. This knowledge gap leads to significant mismatches between developed products and clinical needs. Despite advancements in generative AI that enhance the speed of market research and proposal drafting, the technology is limited to processing data and literature while neglecting the core issues faced by physicians and patients on the ground. Thus, organizations unaware of the realities in the healthcare environment often find their finished products unused, incurring additional financial and reputational damages. Doctors Inc. has thus consolidated its knowledge into the Doctors Brain™ service, merging the ease of contract, real-world insights, and business translation into a single offering.

Features of Doctors Brain™

1. Ease of Entry

Doctors Brain™ redefines consulting norms that have historically been regarded as costly and slow. At just ¥50,000 a month, companies can initiate analysis and testing without incurring exorbitant fees.

2. Continuity in Development

Initial verification efforts under Doctors Brain™ serve as a starting point, integrating all phases necessary to deliver verified ideas into real medical settings without switching providers.

• - Requirement Definition and Clinical Verification: Utilizing a network of over 75,000 affiliated medical institutions for prototype testing.
• - Regulatory Approvals and Insurance Strategies: Supporting compliance with complex regulations for Software as a Medical Device (SaMD) and more.
• - Distribution and Implementation: Facilitating deployment to medical institutions through Doctors Hub®.

The initial verification offered at this accessible price underscores Doctors Inc.'s commitment to preventing setbacks and ensuring the broader success of healthcare projects.

Future Prospects

Doctors Inc. is more than just a consulting firm; it encompasses several medical entities and pharmacies within its group, deeply understanding realities from within the healthcare system rather than just listening from the outside. This insider knowledge enables the company to provide support that transcends theoretical approaches in business development. Through its service, Doctors Inc. aims to lower the initial risks that companies face entering the challenging healthcare market, fostering effective business development. Their long-term vision is to accelerate the arrival of innovative digital health services to clinical environments and individuals' daily lives, acting as a critical “platform for societal implementation of healthcare” and contributing to the advancement of healthcare digital transformation (DX) in Japan.

Service Overview

Conclusion

As Japan advances towards a digital health era, Doctors Inc. is poised to lead the charge in delivering substantive digital health services rooted in real medical practice. The launch of Doctors Brain™ stands as a testament to their commitment to revolutionizing healthcare service provision.